С. В. Семочкин

639 total citations
35 papers, 94 citations indexed

About

С. В. Семочкин is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, С. В. Семочкин has authored 35 papers receiving a total of 94 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 16 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in С. В. Семочкин's work include Multiple Myeloma Research and Treatments (20 papers), Protein Degradation and Inhibitors (9 papers) and Peptidase Inhibition and Analysis (7 papers). С. В. Семочкин is often cited by papers focused on Multiple Myeloma Research and Treatments (20 papers), Protein Degradation and Inhibitors (9 papers) and Peptidase Inhibition and Analysis (7 papers). С. В. Семочкин collaborates with scholars based in Russia, United States and United Kingdom. С. В. Семочкин's co-authors include David Simpson, Miklós Egyed, Asher Chanan‐Khan, Samuel Vokurka, Anna Schuh, Robin Foà, Andrey Zaritskey, Jeannine Kassis, Jennie Zhang and А. С. Лучинин and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Oncology.

In The Last Decade

С. В. Семочкин

23 papers receiving 90 citations

Peers

С. В. Семочкин

GENET

HEMAT

PFM

ONCOL

Jennie Zhang United States

Krista M. Isaac United States

Zachary A. Hing United States

Felix Seyfried Germany

Evridiki Michalis Greece

Marina Deodato Italy

Gian Matteo Pica France

Ralph Schulz Germany

Johan A. Dobber Netherlands

Gloria Margiotta Casaluci Italy

Jennie Zhang United States

С. В. Семочкин

79 ×1.8

GENET

50 ×1.1

HEMAT

50 ×1.5

PFM

21 ×0.7

ONCOL

23 ×0.8

Citations per year, relative to С. В. Семочкин С. В. Семочкин (= 1×) peers Jennie Zhang

Countries citing papers authored by С. В. Семочкин

Since Specialization

Citations

This map shows the geographic impact of С. В. Семочкин's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by С. В. Семочкин with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites С. В. Семочкин more than expected).

Fields of papers citing papers by С. В. Семочкин

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by С. В. Семочкин. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by С. В. Семочкин. The network helps show where С. В. Семочкин may publish in the future.

Co-authorship network of co-authors of С. В. Семочкин

This figure shows the co-authorship network connecting the top 25 collaborators of С. В. Семочкин. A scholar is included among the top collaborators of С. В. Семочкин based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with С. В. Семочкин. С. В. Семочкин is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Семочкин, С. В., et al.. (2025). Current Strategy and Principles of Multiple Myeloma Treatment: A Literature Review. Clinical oncohematology. 18(2). 153–162.

Vorobyev, Vladimir, et al.. (2025). Anti-CD38 Antibodies in Monotherapy for Patients with Relapsed/Refractory Multiple Myeloma: Real-World Clinical Practice and Results of Clinical Trials. Clinical oncohematology. 18(2). 145–152.

Лучинин, А. С. & С. В. Семочкин. (2024). Very good partial remission predicts progression-free survival in patients with multiple myeloma. SHILAP Revista de lepidopterología. 19(1). 51–55.

Семочкин, С. В.. (2023). Pathophysiology and treatment of pain in multiple myeloma. Meditsinskiy sovet = Medical Council. 75–89.

Семочкин, С. В., et al.. (2022). Difficulties in diagnosing ALK-negative anaplastic large cell lymphoma manifesting from a skin lesion. Russian Journal of Skin and Venereal Diseases. 25(6). 25–32.

Семочкин, С. В., et al.. (2022). Prevention and management of bortezomib-induced peripheral neuropathy in patients with multiple myeloma. SHILAP Revista de lepidopterología. 17(2). 141–150. 3 indexed citations

Семочкин, С. В.. (2020). Long-term continuous treatment as a new strategy for relapsed or refractory multiple myeloma. SHILAP Revista de lepidopterología. 15(2). 29–41.

Семочкин, С. В., et al.. (2019). Practical Aspects of the Use of Carfilzomib in Multiple Myeloma. SHILAP Revista de lepidopterología. 12(1). 21–31. 1 indexed citations

Семочкин, С. В., et al.. (2019). N-Terminal Fragment of Brain-Type Natriuretic Peptide (NT-proBNP) as a Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Complicated by Dialysis-Dependent Renal Failure. Bulletin of Experimental Biology and Medicine. 167(2). 267–271. 2 indexed citations

10.

Семочкин, С. В.. (2018). Ixazomib in the treatment of relapsed multiple myeloma. Meditsinskiy sovet = Medical Council. 84–91. 1 indexed citations

11.

Семочкин, С. В., et al.. (2018). Evolution of Anti-Cancer Treatment and its Impact on Surrogate Prognostic Factors in Multiple Myeloma. Clinical oncohematology. 11(2). 175–181. 1 indexed citations

12.

Семочкин, С. В., et al.. (2018). Diagnosis and principles of therapy of multiple myeloma. 2_2018. 15–22.

13.

Семочкин, С. В., et al.. (2017). Multiple myeloma complicated by concomitant cardiac pathology. Annals of Oncology. 28. v366–v366. 1 indexed citations

14.

Лучинин, А. С., et al.. (2017). EPIDEMIOLOGY OF MULTIPLE MYELOMA ACCORDING TO THE КIROV REGION POPULATION REGISTERS. Oncohematology. 12(3). 50–56. 10 indexed citations

15.

Семочкин, С. В., et al.. (2015). Clinical and epidemiological characteristics of acute myeloid leukemias in adults according to the data of municipal hematology departments in Moscow. Terapevticheskii arkhiv. 87(7). 26–26. 3 indexed citations

16.

Семочкин, С. В., et al.. (2015). Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study. SHILAP Revista de lepidopterología. 10(1). 16–23. 1 indexed citations

17.

Пирадов, М. А., et al.. (2014). [POEMS-syndrome: a literature review and case reports].. PubMed. 114(4). 4–10. 7 indexed citations

18.

Семочкин, С. В., et al.. (2014). Thyroid disorders after radiation therapy in childhood. SHILAP Revista de lepidopterología. 10(3). 45–45.

19.

Семочкин, С. В., et al.. (2014). Russian experts' clinical guidelines for acute myeloid leukemia treatment in patients less than 60 years of age. SHILAP Revista de lepidopterología.

20.

Семочкин, С. В., et al.. (2014). Quality of life in adolescent and young adult Hodgkin’s lymphoma survivors. Clinical oncohematology. 7(2). 184–191.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact